title: [Is heart transplantation for primary cardiac sarcoma a useful therapeutic option?].
abstract: Primary cardiac sarcomas are rapidly progressive malignant tumors. No good therapeutic option is known. In recent years, heart transplantation has sometimes been performed in selected patients with cardiac sarcoma.We retrospectively analyzed 8 patients with primary cardiac sarcoma referred to our center to undergo assessment for heart transplantation. After an exhaustive study of the extension of the tumor, 6 patients were added to the waiting list for heart transplantation. Heart transplantation was not performed in 3 of these patients due to evidence of extracardiac extension, but the procedure was completed in the remaining 3 patients. The median survival in intention-to-treat analysis (transplantation or a frustrated transplantation attempt) was 8.5 months. Overall, the median survival of the 3 patients who underwent transplantation (12 months) was similar to that of the 5 patients who did not (11 months).
authors.affiliation: Servicio de Cardiología. Clínica Puerta de Hierro. Madrid. España. jimenezmazuecos@hotmail.com
authors.forename: Jesús M
authors.initials: JM
authors.lastname: Jiménez Mazuecos
authors.forename: Raquel
authors.initials: R
authors.lastname: Fuentes Manso
authors.forename: Javier
authors.initials: J
authors.lastname: Segovia Cubero
authors.forename: Jorge
authors.initials: J
authors.lastname: Toquero Ramos
authors.forename: Juan F
authors.initials: JF
authors.lastname: Oteo Domínguez
authors.forename: Luis
authors.initials: L
authors.lastname: Alonso-Pulpón Rivera
mesh_terms: D000328:Adult; D005260:Female; D006338:Heart Neoplasms / Q000401:mortality / Q000473:pathology / Q000601:surgery*; D016027:Heart Transplantation / Q000379:methods / Q000401:mortality; D006801:Humans; D008297:Male; D009206:Myocardium / Q000473:pathology; D012509:Sarcoma / Q000401:mortality / Q000473:pathology / Q000601:surgery*; D016019:Survival Analysis; D016896:Treatment Outcome
vernacular_title: ¿Es útil el trasplante cardíaco como tratamiento del sarcoma cardíaco primario?